These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28335462)

  • 1. Therapeutic Potentials of Microalgae in the Treatment of Alzheimer's Disease.
    Olasehinde TA; Olaniran AO; Okoh AI
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28335462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, β-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
    Dash UC; Swain SK; Kanhar S; Banjare P; Roy PP; Dandapat J; Sahoo AK
    J Ethnopharmacol; 2022 Jan; 282():114637. PubMed ID: 34534598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effects of Quercetin in Alzheimer's Disease.
    Khan H; Ullah H; Aschner M; Cheang WS; Akkol EK
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
    Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
    BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review.
    Lee JY; Wong CY; Koh RY; Lim CL; Kok YY; Chye SM
    Yale J Biol Med; 2024 Jun; 97(2):205-224. PubMed ID: 38947104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous-ethanol extracts of some South African seaweeds inhibit beta-amyloid aggregation, cholinesterases, and beta-secretase activities in vitro.
    Olasehinde TA; Olaniran AO; Okoh AI
    J Food Biochem; 2019 Jul; 43(7):e12870. PubMed ID: 31353743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer's disease.
    Puksasook T; Kimura S; Tadtong S; Jiaranaikulwanitch J; Pratuangdejkul J; Kitphati W; Suwanborirux K; Saito N; Nukoolkarn V
    J Nat Med; 2017 Oct; 71(4):665-682. PubMed ID: 28600778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Wang J; Cai P; Yang XL; Li F; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2017 Oct; 139():68-83. PubMed ID: 28800459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer's Disease Pathophysiological Hallmarks.
    Benfeito S; Fernandes C; Vilar S; Remião F; Uriarte E; Borges F
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
    García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.
    Estrada M; Pérez C; Soriano E; Laurini E; Romano M; Pricl S; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
    Future Med Chem; 2016 Jul; 8(11):1191-207. PubMed ID: 27402296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
    Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
    Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of multi-target compounds as AChE, BACE1, and amyloid-β(1-42) oligomerization inhibitors: in silico and in vitro studies.
    Hernández-Rodríguez M; Correa-Basurto J; Martínez-Ramos F; Padilla-Martínez II; Benítez-Cardoza CG; Mera-Jiménez E; Rosales-Hernández MC
    J Alzheimers Dis; 2014; 41(4):1073-85. PubMed ID: 24762947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural antioxidants in Alzheimer's disease.
    Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
    Mishra CB; Manral A; Kumari S; Saini V; Tiwari M
    Bioorg Med Chem; 2016 Aug; 24(16):3829-41. PubMed ID: 27353888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines.
    Oset-Gasque MJ; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3349-3360. PubMed ID: 29332585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.